Advertisement
Advertisement
Business /

Investor Relations

The inspection will focus on whether banks have complied with a circular outlining expectations on staffing and quality controls when handling IPOs, according to the SFC. Photo: Yik Yeung-man
Hong Kong stock market

SFC prepares to inspect Hong Kong IPO listing sponsors amid quality concerns

Market regulator will soon begin inspection of investment banks amid concerns about deficiencies in listing documents and misconduct.

China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Hong Kong stock market

Hong Kong stocks edge higher as oil steadies, tracking Wall Street gains

Banking & finance

Hong Kong attracts wave of biotech IPO filings amid AI drug research boom

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest.

The latest applications come as healthcare and biotechnology equity capital market activity in Hong Kong reached US$15.6 billion last year. Illustration: Shutterstock
The latest applications come as healthcare and biotechnology equity capital market activity in Hong Kong reached US$15.6 billion last year. Illustration: Shutterstock
Banking & finance

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

IPO

Hong Kong’s IPO pace picks up as 2 mainland Chinese firms get listing approval

Everdisplay Optronics and Galaxis Technology publish post-hearing information packs on the Hong Kong stock exchange.

Advertisement
Advertisement
Advertisement
Insilico

Insilico Medicine advances Middle East push with UAE AI drug discovery deal

Hong Kong-listed biotech firm’s shares jump after announcing partnership to use AI tools in drug discovery in the United Arab Emirates.

The agreement was reached during the World Health Expo in Dubai between February 9 and 12, about two weeks before the United States and Israel launched military strikes on Iran. Photo: Shutterstock
The agreement was reached during the World Health Expo in Dubai between February 9 and 12, about two weeks before the United States and Israel launched military strikes on Iran. Photo: Shutterstock
Made in China 2025

China biotech outlicensing tops US$52 billion in first 2 months

The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB.

IPO

HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings

Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.

Hong Kong stock market

The big cornerstone comeback: what’s driving investors back to Hong Kong IPOs?

After four subdued years, the cornerstone investors that anchor Hong Kong’s IPO market are returning in force, reshaping the deal landscape.

Illustration: Lau Ka-kuen
China stock market

US investors increase buying of Hong Kong, mainland Chinese stocks

American investors bought US$15 billion of Hong Kong and mainland stocks in 2025, as buying picked up steam through the year.

A man walks on illuminated stairs at M+ Museum in West Kowloon as Hong Kong’s skyline is seen in a reflection on May 28, 2025. Photo: Eugene Lee
A man walks on illuminated stairs at M+ Museum in West Kowloon as Hong Kong’s skyline is seen in a reflection on May 28, 2025. Photo: Eugene Lee
Hong Kong stock market

Hong Kong stocks retreat on AI worries, China markets rally in Year of the Horse

Tech heavyweights drag Hong Kong stocks lower as investors fret over AI disruption following Wall Street’s decline.

Hong Kong stock market

Hong Kong stocks gain by most in nearly a month on China export optimism

‘China and Hong Kong are the biggest beneficiaries’ of US court decision on tariffs, Goldman Sachs strategists and economists say.

Hong Kong stock market

Hong Kong stocks fall as market reopens after 3-day Lunar New Year holiday

Tech heavyweights Alibaba, Baidu and Kuaishou drop as trading commences in the Year of the Horse.

Hong Kong stock exchange in Central. Photo: Jonathan Wong
Hong Kong stock market

Hong Kong stocks rise to wrap up best lunar-year performance in eight years

As market closes for Lunar New Year, benchmark hits 32 per cent gain since the Year of the Snake began in January 2025.

A sign in Central shows Hong Kong stock information on February 6, 2026. Photo: Jonathan Wong
A sign in Central shows Hong Kong stock information on February 6, 2026. Photo: Jonathan Wong
Hong Kong stock market

Korean investors pour US$92.5 million into Hong Kong AI, tech stocks

Return to mainland equities bends towards start-ups and ETFs, versus earlier focus on bellwether, large-cap names.

Hong Kong stock market

Hong Kong stocks slip as regulator summons tech firms over train tickets

Approaching Lunar New Year holiday also dampens investors’ enthusiasm for technology stocks, analyst says.

Advertisement
Advertisement
Advertisement
IPO

Shenzhen-listed Unisplendour abandons plan to raise funds in Hong Kong

The Tsinghua Holdings arm, however, will raise US$800 million via a private share placement on Shenzhen exchange.

Unisplendour was expected to raise US$1 billion from its Hong Kong share sale this year. Photo: Reuters
Unisplendour was expected to raise US$1 billion from its Hong Kong share sale this year. Photo: Reuters
Hong Kong stock market

Hong Kong stocks rise as positive holiday bias sets in ahead of Lunar New Year

Southbound net inflows reflect investor optimism about Hong Kong stocks after the holiday, analyst says.

Made in China 2025

Chinese healthcare firms expand overseas to support growing expat community

Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.

Banking & finance

Mainland China’s investors pour into Hong Kong-listed drug stocks

An index tracking Stock Connect buying of 40 mainland drug firms gains 9 per cent in a week as China’s industry heft grows.

An employee works on a drug production line at a pharmaceutical company in Meishan, China, on January 30, 2024. Photo: NurPhoto via Getty Images
Hong Kong

AI chip supplier Axera trades flat in Hong Kong debut as investor frenzy cools

Axera attracted HK$22.34 billion from retail investors during the bookbuilding period, marking an oversubscription of 74.4 times.

Axera specialises in designing AI perception and edge computing chips for applications such as smart vehicles. Photo: Handout
Axera specialises in designing AI perception and edge computing chips for applications such as smart vehicles. Photo: Handout
Banking & finance

China slashes wait times for loss-making tech firms seeking refinancing, fundraising

Three of China’s stock exchanges have relaxed fundraising time thresholds on listed tech companies as Beijing pushes for self-reliance.

videocam
Hong Kong stock market

Tech sell-off rattles investors with cross-asset volatility set to linger

Markets swing sharply across asset classes as AI forces a rethink of pricing power and long-term growth bets.

Made in China 2025

Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal

The deal comes as Chinese novel drug makers are having more say in how their new medicines are developed with global partners.

A view of the Shanghai facility of Fosun Pharma’s biopharma unit Henlius. Photo: Handout
Help preserve 120 years of quality journalism.
SUPPORT NOW